Arrowhead Pharmaceuticals · 19 hours ago
Director, Trade & Distribution
Pasadena, California, United States
Full-time
Onsite
Lead/Staff, Director/Executive
$230K/yr - $250K/yr
5+ years expArrowhead Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative drugs for diseases with a genetic basis. The Director, Trade & Distribution will lead the evolution of the trade and distribution strategy to support the transition to a broader patient population and optimize patient access for Redemplo.
BiotechnologyHealth CareNanotechnologyPharmaceutical
No H1B
Responsibilities
Recommend expansion of the current distribution model to support Redemplo’s launch and scalability for future indications
Lead the development and execution of strategy, including distribution design, vendor selection, and end-to-end implementation
Serve as the trade relations lead for negotiations, contracting, and onboarding of Specialty Pharmacies, Third-Party Logistics providers (3PLs), Specialty Distributors, and/or full-line Wholesalers, as required
Provide leadership and people management to teams executing assigned programs and initiatives
Define and establish service levels, data reporting requirements, and key performance indicators (KPIs) / service level agreements (SLAs) to support the operating model
Collaborate with patient services partners to ensure optimal customer experience for patients and physicians accessing Redemplo
Implement and manage contracts to ensure adherence to agreed-upon service levels, budgets, and timelines
Define required operational capabilities, including data flows, program management infrastructure, and performance monitoring
Own accountability for managing channel partners to ensure timely, high-quality, and fiscally responsible execution; proactively anticipate risks and implement course corrections as needed
Maintain deep expertise in the IDN, ACO, and GPO hospital specialty pharmacy landscape to ensure appropriate breadth and depth of distribution
Develop and maintain reporting requirements, standard operating procedures (SOPs), and policies to ensure program readiness, operational excellence, and compliance
Communicate goals, progress, risks, and mitigation plans for critical launch-related activities through quarterly business reviews and other governance forums
Collaborate cross-functionally with Supply Chain, CMC, Regulatory, Legal, Marketing, Finance, Sales, Commercial Operations, Quality, and other stakeholders, as required
Qualification
Required
Bachelor's degree required, preferably in health sciences, business, or marketing
0+ years of experience in the biotech or pharmaceutical industry, including at least 5+ years in Market Access, Trade & Distribution, or related functions
Demonstrated U.S. new product launch experience required; specialty pharmaceutical launch experience strongly preferred
Experience supporting expansion from rare disease to larger patient populations is highly desirable
Proven experience building, leading, and developing high-performing teams
Strong understanding of the U.S. pharmaceutical supply chain, including hands-on experience with distribution models, pharmacy benefit channels, IDN/ACO/GPO hospital distribution, and government programs such as 340B, State Medicaid, and Medicare Part D
Working knowledge of regulatory requirements, SOPs, and policies governing drug distribution
Demonstrated capabilities in data analytics, business planning, negotiations, financial acumen, contract execution/pull-through, and structured problem-solving
Highly organized and detail-oriented, with strong written, presentation, and proactive communication skills
Willingness to travel as needed to engage with customers, as required
Preferred
Advanced degree (e.g., MBA or Master's in a related field)
Passion for science-driven storytelling and an interest in Arrowhead's mission to advance RNAi-based therapeutics
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.45BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M
Leadership Team
Christopher Anzalone
President and Chief Executive Officer
Recent News
2026-01-14
Company data provided by crunchbase